“ Mirvaso Gel is an important breakthrough to address the unmet need of treating the persistent facial redness of rosacea,” said Mark Jackson, M.D., Clinical Professor of Medicine at the University of ...

Mirvaso (brimonidine; Galderma) Topical Gel 0.33% is now available in a pump dispenser. Galderma announced the availability of Mirvaso (brimonidine) Topical Gel 0.33% in a new pump delivery system, ...

Galderma Laboratories recently announced that a new pump dispenser design for Mirvaso topical gel, 0.33% is available to treat persistent erythema associated with rosacea in adults. Mirvaso ...

MIRVASO (brimonidine) 0.33% Topical Gel The FDA has approved Galderma's Mirvaso (brimonidine) topical gel for the topical treatment of the facial erythema associated with rosacea in adults 18 years or ...

- Galderma portfolio expands to offer a fast onset and long-acting alpha-2 adrenergic receptor agonist - Galderma, a leading global pharmaceutical company exclusively focused on dermatology, today ...

FORT WORTH, Texas--(BUSINESS WIRE)--Galderma Laboratories, L.P., a global leader focused on medical treatment options in dermatology and skin health and the maker of Cetaphil®, today announced the ...

NEW YORK (CBSNewYork) --Do you blush easily or often have red, rosy cheeks? You may have a skin condition call rosacea. The Food & Drug Administration has approved a new gel to treat the embarrassing ...

A new gel containing an ingredient previously used in eye drops could be the solution to embarrassing and often painful facial flushing. Mirvaso will be available on prescription only for patients ...

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing of brimonidine tartrate 3 mg/g topical gel (Mirvaso, Galderma) for the symptomatic ...

Rosacea is a chronic relapsing disease of the facial skin, characterised by recurrent episodes of facial flushing, persistent erythema, telangiectasia (fine, dilated blood vessels), papules and ...

A new treatment could help millions suffering from rosacea - a skin disorder causing embarrassing facial redness. The skin gel is the first prescription drug available on the NHS to dramatically cut ...

Galderma, a leading global pharmaceutical company exclusively focused on dermatology, today announced that the European Commission has granted Marketing Authorisation in Europe for Mirvaso(R) ...